Endurant Stent-Graft: A 2-Year, Single-Center Experience With a New Commercially Available Device for the Treatment of Abdominal Aortic Aneurysms

Authors:

Abstract
Purpose: To evaluate early and midterm results of the Endurant stent-graft in the treatment of abdominal aortic aneurysms (AAAs). Methods: From November 2007 to December 2009, 156 patients (142 men; mean age 73.6 years, range 51–90) were treated with the Endurant stent-graft at our center. More than half (106, 67.9%) had hostile proximal neck anatomy. Early (30-day) technical success, clinical success, major morbidity, and mortality rates were analyzed, as well as estimated 2-year survival, freedom from types I/III endoleak, freedom from graft thrombosis, freedom from any device-related reinterventions, and factors affecting 2-year freedom from types I/III endoleak. Results: Immediate intraoperative technical and clinical success was achieved in all cases. In 14 (9%) cases with a proximal neck Conclusion: The Endurant stent-graft seems to be safe and effective in endovascular aneurysm repair (EVAR), even in patients with hostile aortoiliac anatomy. However, perioperative and midterm complications occur, which could be explained by the expansion of indications for EVAR. Further studies are needed to evaluate the long-term results.

This publication has 37 references indexed in Scilit: